Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Antibody-drug conjugate carries a chemotherapy drug directly to cancerous B cells.
Approval was based on the results of two clinical trials: AUGMENT and MAGNIFY.
An ongoing study is assessing pediatric and young adult cancers that did not respond to initial treatments.
Study found Venclexta plus Gazyva (obinutuzumab) delayed disease progression in previously untreated patients.
Many vaccines are preventive. This is a THERAPEUTIC vaccine: it teaches your immune system to recognize the problem AFTER you have it.
Umbralisib may offer a chemotherapy-free option for people with relapsed or nonresponsive marginal zone lymphoma.
In a small clinical trial, the vaccine trained the immune system to recognize tumors and attack them in people with lymphoma.
Global reports show nearly 250 new cases of non-Hodgkin lymphoma in women with breast implants.
Long-term remission seen in children with leukemia and adults with lymphoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.